71519-70-5

Usage

Uses

Used in Pharmaceutical Industry:
1-(2-amino-1,3-thiazol-5-yl)-1,4-anhydropentitol is used as a potential drug candidate for its antiviral and antifungal properties, making it a promising compound for the development of new treatments for various diseases.
Used in Antiviral Applications:
1-(2-amino-1,3-thiazol-5-yl)-1,4-anhydropentitol is used as an antiviral agent due to its potential to inhibit viral replication and reduce the severity of viral infections.
Used in Antifungal Applications:
1-(2-amino-1,3-thiazol-5-yl)-1,4-anhydropentitol is used as an antifungal agent for its ability to combat fungal infections and prevent the growth of fungi.
Further research is required to explore the full potential of 1-(2-amino-1,3-thiazol-5-yl)-1,4-anhydropentitol in various applications and to optimize its use in the medical field.

Upstream product

• 71519-54-5 (2ξ)-3,6-anhydro-2-deoxy-2-bromo-4,5-O-isopropylidene-7-O-trityl-D-allo-heptose 
• 130222-84-3 5-(tert-butyldiphenylsilyl)-2,3-O-isopropylidene-D-ribono-1,4-lactone 
• 543729-91-5 [5-((R)-{(4S,5R)-5-[(R)-2-(tert-Butyl-diphenyl-silanyloxy)-1-hydroxy-ethyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-hydroxy-methyl)-thiazol-2-yl]-carbamic acid tert-butyl ester 
• 543729-97-1 {5-[6-(tert-butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-thiazol-2-yl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

A short and highly stereoselective synthesis of α-(2-aminothiazolyl)-C-nucleosides

A short route to novel α-(2-aminothiazolyl)-C-nucleosides has been developed. The key step was the high diastereoselective reduction of the hemiacetal intermediates using L-Selectride, which afforded the corresponding R-diols in quantitative yields. These diols were converted, after C4-C1 ring closure and protecting groups cleavage, to their corresponding free α-C-nucleosides.

Efficient stereoselective synthesis of new C-nucleosides via intramolecular Mitsunobu cyclization

We have studied the stereoselective synthesis of new C-nucleosides by heteroarylation of the protected γ-ribonolactone by means of heteroaromatic systems such as indole, thiazoles, imidazoles and benzimidazoles. We have observed that the first anion addit